The study authors said they aimed to develop a robust and safe Crispr-Cas regimen, striving for an inclusive HIV cure for all that can inactivate diverse HIV strains across various cellular contexts.
Trending
- Guinea eliminates sleeping sickness as a public health problem
- Lagos butchers worried as daily slaughter drops to 3,000
- UNAIDS commends U.S. decision to continue funding life-saving HIV treatment
- Fidelity Bank chairman, Chike-Obi receives Lifetime Achievement Award
- Kebbi govt shifts 61st Argungu International Fishing Festival to 2026
- Nigeria’s e-payment transactions soar to record N1.07 quadrillion in 2024
- Microsoft, OpenAI investigate possible data breach by Chinese AI startup DeepSeek
- Paradigm Initiative: Data privacy awareness in Nigeria still poor
